SCHEMBL6654086

SCHEMBL6654086

Cc1[nH]c2ccc(CCN3CC4(C)CC3CC(C)(C)C4)cc2c1C(=O)OCc1ccccc1.Cc1[nH]c2ccc(CCOS(C)(=O)=O)cc2c1C(=O)OCc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
HPGD P15428 1/20 0.38
KDM4E B2RXH2 2/20 0.36
GAA P10253 1/20 0.35
HSD17B10 Q99714 2/20 0.34
ALOX5 P09917 1/20 0.34
LMNA P02545 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM5 P08912 1/20 0.34
CHRM1 P11229 1/20 0.34
CHRM3 P20309 1/20 0.34
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
AVPR2 P30518 1/20 0.33
AVPR1A P37288 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6315962 0.93 ALDH1A1 (0.43) ALDH1A1HPGDKDM4EGAAHSD17B10
SCHEMBL6317452 0.84 KDM4E (0.42) ALDH1A1HPGDKDM4EGAAHSD17B10
SCHEMBL6316385 0.82 GAA (0.49) ALDH1A1HPGDKDM4EGAAHSD17B10
SCHEMBL6654552 0.80 CHRM2 (0.36) ALDH1A1HPGDKDM4EGAAHSD17B10
SCHEMBL6659460 0.79 GAA (0.39) ALDH1A1KDM4EGAAALOX5LMNA
SCHEMBL6651182 0.79 DRD2 (0.44) ALDH1A1KDM4EGAAALOX5LMNA
SCHEMBL6649651 0.76 CCR5 (0.36) GAAALOX5CHRM2CHRM4CHRM5
SCHEMBL6314397 0.73 HRH3 (0.51) ALDH1A1TSHR
SCHEMBL6316026 0.72 GAA (0.47) ALDH1A1HPGDKDM4EGAAHSD17B10
SCHEMBL6316042 0.72 GAA (0.47) ALDH1A1HPGDKDM4EGAAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1377549-A1 FUNCTIONALIZED HETEROCYCLES AS MODULATORS OF CHEMOKINE RECEPTOR FUNCTION AND METHODS OF USE THEREFOR Millennium Pharmaceuticals, Inc. (US) 2004-01-07 EP disclosed
WO-2002072549-A1 FUNCTIONALIZED HETEROCYCLES AS MODULATORS OF CHEMOKINE RECEPTOR FUNCTION AND METHODS OF USE THEREFOR MILLENNIUM PHARMACEUTICALS, INC. (US) 2002-09-19 WO disclosed